Schizophrenia - Cognitive remediation

-

References & Bibliography


Books
Spaulding WD, eds. (1994)Cognitive technology in psychiatric rehabilitation. Lincoln, NE: University of Nabraska Press.
 * Frith, C. D. (1992). The cognitive neuropsychology of schizophrenia. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc.
 * Margolin DI, eds.(1992) Cognitive neuropsychology in clinical practice. New York: Oxford University Press.

Papers
cognitive deficits in schizophrenia. American Journal of Psychiatry, 147, 1650-5. vulnerability factors in schizophrenia: implications for treatment. British Journal of Psychiatry, 161(Supplement 18), 154-63. der rehabilitation chronisch schizophrener patienten]. Der Nervenarzt, 51, 106-12. rehabilitation for improving attention in patients with schizophrenia. Occupational Therapy Journal of Research, 13, 71-86 the social impairment and negative symptoms accossiated with chronic mental illness. Journal of Psychotherapy Practice and Research, 7, 167-76. schizophrenia. Psychological Medicine, 23, 221-7. NE: University of Nabraska Press. intervention in rehabilitation of clients with schizophrenia. Clinical Rehabilitation, 15, 349-59. diseases. Psychiatr Neurol Med Psychol (Leipz)., 41, (6) 367-75. Description of the training and results of a controlled therapeutic study. Nervenarzt, 58, (2) 91- 6. schizophrenia: implications for cognitive rehabilitation. Neuropsychology, 12, 590-9. prospects for intervention. In T. Wykes, N. Tarrier & S. Lewis (Eds.), Outcomes and innovation in psychological treatment of schizophrenia. Chichester: Wiley. treatment of cognitive impairments. New Directions for Mental Health Services, 53, 7-19. it? Schizophrenia Bulletin, 18, (1) 15-20. evaluation of cognitive adaptation training to compensate for cognitive deficits in schizophrenia. Psychiatric Services, 47, 415-7. sychopharmacology, 124, 168-175. van Minnen, A., Hoogduin, C. A., & Broekman, T. G. (1997). Hospital versus outreach treatment of patients with mental retardation and psychiatric disorders: a controlled study. Acta Psychiatrica Scandinavica, 95, 515-22. van Os, J., Takei, N., Castle, DJ., Wessely, S., Der, G., MacDonald, A. M., & Murray, R. M. (1996). The incidence of mania: time trends in relation to gender and ethnicity. Social Psychiatry and Psychiatric Epidemiology, 31, (3-4) 129-36. Van Putten, T., Marder, S. R. (1986). Low-dose treatment strategies. Journal of Clinical Psychiatry, 47, (Suppl 5) 12-6. Van Wyk, A. J., & Grove, J. J. (1972). Pimozide: an effective, once daily oral therapy for schizophrenia. South African Medical Journal, 46, 515-7. Van Wyk, A. J., & Marais, G. F. (1971). Chlorpromazine, clotiapine and thioridazine--a comparative clinical trial on Bantu psychotic patients. South African Medical Journal, 45, (34) 945-7. Vanelle, J. M. (1996). Profil d'action des neuroleptiques dans les schizophrenies defictaires. L'Encephale, (Suppl. II) 33-9. Vannicelli, M., Washburn, S., Scheff, B. J, & Longabaugh, R. (1978). Comparison of usual and experimental patients in a psychiatric day center. Journal of Consulting and Clinical Psychology, 46, 87-93. Varma, V. K., & Kulhara, P. (1989) Open drug trial with haloperidol decanoate injections in schizophrenia. Indian Journal of Psychiatry, 31, (2) 144-50. Vasavan Nair, N. P., Suranyi-Cadotte, B., Schwartz, G., Thavundayil, J. X., Achim, A., Lizondo, E., Nayak, R. (1986). A clinical trial comparing intramuscular haloperidol decanoate and oral haloperidol in chronic schizophrenic patients: efficacy, safety, and dosage equivalence. Journal of Clinical Psychopharmacology, 6, (1) 30-7S. Vaughan, K., Doyle, M., McConaghy, N., Blaszczynski, A., Fox, A., & Tarrier, N. (1992). The Sydney intervention trial: a controlled trial of relatives' counselling to reduce schizophrenic relapse. Social Psychiatry and Psychiatric Epidemiology, 27, 16-21. Vaughn, C. E., & Leff, J. P. (1976). The influence of family and social factors on the course of psychiatric illness. A comparison of schizophrenic and depressed neurotic patients. British Journal of Psychiatry, 129, 125-37. Veerecken, J. L. T. H., & Tanghe, A. (1972). Fluspirilene and pipothiazine undecylenate, two long-acting injectable neuroleptics. Psychiatria, Neurologia, Neurochirurgia, 75, 117-27. Velasquez, J. S., & McCubbin, H. I. (1980). Towards establishing the effectiveness of community-based residential treatment: program evaluation by experimental research. Journal of Social Service Research, 3, 337-59. Schizophrenia: full guideline – Appendix 21 (pre-publication draft) 66 2 Velligan, D. I. PJCJGHALMRMAL, & Newcomer JW. (1999).Changes in cognitive function with quetiapine fumarate versus haloperidol. 152nd Annual Meeting of the American Psychiatric Association. Washington DC, USA. 15-20th May, 1999. 1999.
 * Adams, H.E., Malatesta, V., Brantley, P.J., Turkat, I.D. (1981). Modification of cognitive processes: a case study of schizophrenia. Journal of Consulting and Clinical Psychology, 49, 460-4.
 * Ahmed, M., Goldman, J.A. (1994). Cognitive rehabilitation of adults with severe and persistent mental illness: a group model. Community Mental Health Journal, 30, 385-93.
 * Bellack, A.S., Mueser, K.T., Morrison, R.L., Tierney, A., Podell, K. (1990). Remediation of
 * Brenner, H.D., Hodel, B., Genner, R., Roder, V., Corrigan, P. (1992). Biological and cognitive
 * Brenner, H.D., Hodel, B., Roder, V., Corrigan, P. (1992). Treatment of cognitive dysfunctions and behavioral deficits in schizophrenia. Schizophrenia Bulletin, 18, 21-6.
 * Brenner, H.D., Stramke, W.G., Mewes, F., Liese, F., Seeger, G. (1980). [Erfahrungen mit einem spezifischen therapieprogramm zum training kognitiver and kommunikativer fähigkeiten in
 * Brown, C., Harwood, K., Hays, C., Heckman, J., Short, J.E. (1993). Effectiveness of cognitive
 * Daniels, L. (1998). A group cognitive-behavioural and process-oriented approach to treating
 * Delahunty, A., Morice, R., Frost, B. (1993). Specific cognitive flexibility rehabilitation in
 * Fine, S.B. (1994). In Spaulding WD, ed. Cognitive technology in psychiatric rehabilitation. Lincoln,
 * Hadas-Lidor, N., Katz, N., Tyano, S., Weizman, A. (2001). Effectiveness of dynamic cognitive
 * Heim, M., Wolf, S., Gothe, U., & Kretschmar, J. (1989). Cognitive training in schizophrenic
 * Hermanutz, M., & Gestrich, J. (1987). Cognitive training of schizophrenic patients.
 * Michel, L., Danion, J.M., Grange, D., Sander, G. (1998). Cognitive skill learning and
 * Nuechterlein, K.H. & Subotnik, K.L. (1998). The cognitive origins of schizophrenia and
 * Perris, C. (1992). A cognitive-behavioral treatment program for patients with a schizophrenic disorder. New Directions for Mental Health Services, 53, 21-32.
 * Reed, D., Sullivan, M. E., Penn, D. L., Stuve, P., & Spaulding, W. D. (1992). Assessment and
 * Spring, B. J., & Ravdin, L. (1992). Cognitive remediation in schizophrenia: should we attempt
 * The Scottish Schizophrenia Research Group. (1987). The Scottish first episode schizophrenia study. III. Cognitive performance. British Journal of Psychiatry, 150, 338-40.
 * Velligan, D. I., Mahurin, R. K., True, J. E., Lefton, R. S., & Flores, C.V. (1996). Preliminary

Velligan, D. I., Newcomer, J., Pultz, J. et al. Does cognitive function improve the quetiapine in comparison to haloperidol? Schizophrenia Research, 53, (3) 239-248. Vergara, L., Amin, M. M.,& Ban, T. A. A standard (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients. Psychopharmacology Bulletin, 13, 17-9. Versiani, M., Da Silva, J. A. R., & Mundim FD. Loxapine versus thioridazine in the treatment of organic psychosis. Journal of International Medical Research, 8, (1) 22-30. Versiani, M., da Silva, J. A., Frota, L. H., & Mundim, F. D. (1978). Double-blind comparison between loxapine and haloperidol in the treatment of adolescent schizophrenic patients. Current Therapeutic Research, 24, (5) 559-66. Vestre, N. D., & Schiele, B. C. (1970). Differential drug effects of two phenothiazines (a controlled comparison of thioridazine and trifluoperazine in chronic schizophrenics). Diseases of the Nervous System, 31, (12) 821-5. Viala, A., Ba, B., Durand, A., Gouezo, F., Hou, N., & Jorgensen, A. (1988), Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate. Psychopharmacology, 94, (3) 293-7. Vianna Filho, U., Versiani Caldeira, M. V., & Bueno, J. (1975) Preliminary report on a double blind study comparing loxapine succinate with thiothixene in chronic schizophrenic patients. Jornal Brasileiro de Psiquiatria, 24, (1) 5-27. Vianna-Filho, U., Versiani Caldeira, V., & Romildo Bueno, J. (1975). The efficacy and safety of loxapine succinate in the treatment of schizophrenia: a comparative study with thiothixene. Current Therapeutic Research - Clinical and Experimental, 18, (3) 476-90. Vietze, G., Lange, E., Ficker, F., & Ost, H. (1976) Day-night therapy - a necessary step towards better care for mental patients. Psychiatrie, Neurologie und Medizinische Psychologie, 28, (5) 298- 306. Vinar, O., Bastecky, J., Taussigova, D., Formankova, M., & Ruzicka, S. (1967). Clopenthixol in schizophrenia. Comparison of two groups of patients treated by the same drug. Activitas Nervosa Super Praha, 9, (4) 401-4. Vincent, P., & Price, J. R. (1977). Evaluation of a VNA Mental Health Project. Nursing Research, 26, 361-7. Vital-Herne, J., Gerbino, L., Kay, R., Katz, I. R., & Opler, L. A. (1986). Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics. Journal of Clinical Psychiatry, 47, (7) 375-9. Vlaminck, P. (1990). Community care for schizophrenic patients: the cost and benefits. Maandblad Geestelijke Volksgezondheid, 45, (1) 18-31.

Schizophrenia: full guideline – Appendix 21 (pre-publication draft) 66 3 Volterra, V., de Ronchi, D., Belelli, G., Ruggeri, M., Borsett,i G., & Cotani, P. (1996). Effects of psychodynamic therapy in schizophrenic patients. 10th World Congress of Psychiatry; 1996; Madrid, Spain: 1996. Volterra, V., de Ronchi, D., Belelli, G., Ruggeri, M., Lunardi, A. (1996). Effects of psychodynamic therapy in schizophrenic patients. In American Psychiatric Association, 149th Annual Meeting, 4-9 May, 1996. Vora, S., Layman, W. A., Mann, E. T., & Danesino, A. (1977). The effects of long-term psychotherapy on patients' self-perception. Diseases of the Nervous System, 38, (9) 717-21. Vranckx-Haenen, J., De Munter, W., & Heykants, J. (1979). Fluspirilene (IMAP) administered in a biweekly dose for the prevention of relapses in chronic schizophrenics. Acta Psychiatrica Belgica, 79, 45-74. Vyas, B. K., & Kalla, V. (1980). A six-month double-blind comparison of loxapine succinate and chlorpromazine in chronic schizophrenic patients. Current Therapeutic Research - Clinical and Experimental, 28, (1) 16-30. Wagenaar, G., Pultiere,S., & Liling, C. (1988). Etude clinique du Dogmatil fort (200 mg) dans le traitement des psychoses productives [Clinical trial of high-dose Dogmatil (200 mg) in the management of productive psychoses]. Annales de Psychiatrie, 3, 75-7. Wahlbeck, K., Cheine, M., Tuisku, K., Ahokas, A., Joffe, G., & Rimon, R. (2000). Risperidone versus clozapine in treatment-resistant schizophrenia: a randomised pilot study. Prog Neuro Psychopharmacol Biol Psychiatry, 24 (6), 911-922. Walburn, J., Gray, R., Gournay, K., Quraishi, S., & David, AS., (2001). Systematic review of patient and nurse attitudes to depot antipsychotic medication. British Journal of Psychiatry, 179, 300-7. Walinder, J., Skot, A., Carlsson, A., & Roos, B. E. (1976). Potentiation by metyrosine of thioridazine effects in chronic schizophrenics. A long-term trial using double-blind crossover technique. Archives of General Psychiatry, 33, (4) 501-5. Walker, C. A. (1983). A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients. Pharmatherapeutica, 3, (5) 289-93. Walker, R., Winick, W., Frost, E. S., & Lieberman, J. M. (1969). Social restoration of hospitalised psychiatric patients through a program of special employment in industry.Rehabilitation Literature, 30, 297-303. patients: implications for treatment. Nebraska Symposium on Motivation, 31, 283-317. (1997). Normal neurocognitive performance after extended practice in patients with schizophrenia. Schizophrenia Research, 26, 173-80. remediation on executive processing in patients with schizophrenia. Schizophrenia Bulletin, 25, 292-307. psychosis-cognitive remediation therapy (CRT)? Clinical Psychology Review, (8) 1227-56. neurocognitive remediation on executive processing in patients with schizophrenia. Schizophrenia Bulletin, 25 (2) 291-306. of cognitive remediation therapy (CRT) durable? Results from an exploratory trial.
 * Wallace, C. J., & Boone, S. E. (1983). Cognitive factors in the social skills of schizophrenic
 * Wexler, B. E., Hawkins, K. A., Rounsaville, B., Anderson, M., Sernyak, M. J., & Green, M. F.
 * Wykes, T., Reeder, C., Corner, J., Williams, C., Everitt, B. (1999). The effects of neurocognitive
 * Wykes, T., & van der Gaag, M. (2001). Is it time to develop a new cognitive therapy for
 * Wykes, T., Reeder, C., Corner, J., Williams, C. & Everitt, B. (1999). The effects of
 * Wykes, T., Reeder, C., Williams, C., Corner, J., Rice, C., & Everitt, B. (in press) Are the effects

Papers

 * Google Scholar